Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.980
+0.080 (1.63%)
At close: Apr 1, 2026, 4:00 PM EDT
4.920
-0.060 (-1.20%)
After-hours: Apr 1, 2026, 6:38 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $364.77 million as of April 1, 2026. Its market cap has decreased by -12.54% in one year.
Market Cap
364.77M
Enterprise Value
294.07M
1-Year Change
-12.54%
Ranking
Category
Stock Price
$4.98
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $364.77M, an increase of 64.02%. That is a compound annual growth rate of 11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 358.91M | 15.71% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 374.03M |
| Invivyd | 367.37M |
| Autolus Therapeutics | 367.28M |
| Monopar Therapeutics | 366.74M |
| Enanta Pharmaceuticals | 366.51M |
| Benitec Biopharma | 364.81M |
| DiaMedica Therapeutics | 364.78M |
| Polaryx Therapeutics | 357.92M |